2 results
Approved WMOCompleted
The purpose of this research study is to compare 1 dose (15 ng/kg/minute) of Ularitide with a placebo-substance, to see whether Ularitide is safe and effective for the treatment of acute decompensated heart failure.
Approved WMOWill not start
1. Assess the effectiveness of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2* System on lipid core burden in the study lipid core containing plaque segment(s) as assessed by…